- Home
- CMPO vs IART Comparison
CMPO vs IART Comparison
Compare CMPO & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPO
- IART
- Stock Information
- Founded
- CMPO 2000
- IART 1989
- Country
- CMPO United States
- IART United States
- Employees
- CMPO N/A
- IART N/A
- Industry
- CMPO Finance: Consumer Services
- IART Medical/Dental Instruments
- Sector
- CMPO Finance
- IART Health Care
- Exchange
- CMPO Nasdaq
- IART Nasdaq
- Market Cap
- CMPO 1.5B
- IART 1.7B
- IPO Year
- CMPO N/A
- IART 1995
- Fundamental
- Price
- CMPO $16.11
- IART $21.13
- Analyst Decision
- CMPO Strong Buy
- IART Sell
- Analyst Count
- CMPO 8
- IART 7
- Target Price
- CMPO $16.81
- IART $24.67
- AVG Volume (30 Days)
- CMPO 1.0M
- IART 507.2K
- Earning Date
- CMPO 03-05-2025
- IART 02-25-2025
- Dividend Yield
- CMPO 1.86%
- IART N/A
- EPS Growth
- CMPO N/A
- IART N/A
- EPS
- CMPO N/A
- IART N/A
- Revenue
- CMPO $419,612,000.00
- IART $1,564,920,000.00
- Revenue This Year
- CMPO $10.19
- IART $6.71
- Revenue Next Year
- CMPO $6.41
- IART $6.20
- P/E Ratio
- CMPO N/A
- IART N/A
- Revenue Growth
- CMPO 9.13
- IART 1.45
- 52 Week Low
- CMPO $4.61
- IART $16.81
- 52 Week High
- CMPO $17.71
- IART $45.09
- Technical
- Relative Strength Index (RSI)
- CMPO 53.32
- IART 27.91
- Support Level
- CMPO $14.34
- IART $23.67
- Resistance Level
- CMPO $17.71
- IART $24.69
- Average True Range (ATR)
- CMPO 0.76
- IART 0.89
- MACD
- CMPO 0.12
- IART -0.57
- Stochastic Oscillator
- CMPO 52.52
- IART 0.68
About CMPO CompoSecure Inc.
CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.